Reducing Immune Checkpoint Inhibitor Discontinuation in Dermatomyositis May Improve Survival: A Systematic Review Supplementary Materials

Published: 21 May 2026| Version 1 | DOI: 10.17632/4sgkyg6rn2.1
Contributors:
,
,
,
,

Description

Reducing Immune Checkpoint Inhibitor Discontinuation in Dermatomyositis May Improve Survival: A Systematic Review Supplementary Materials including Supplementary Methods, Supplementary Figure S1, Supplementary Table S1, Supplementary Table S2, and Supplementary Figure S2

Files

Steps to reproduce

See supplementary methods for details.

Institutions

Categories

Autoimmunity, Adverse Effect of Drug, Dermatomyositis, Cutaneous Paraneoplastic Syndrome, Interstitial Lung Disorder, Immune Checkpoint Inhibitor

Licence